Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Income (2018 - 2025)

Neurogene's Net Income history spans 6 years, with the latest figure at -$24.9 million for Q4 2025.

  • For Q4 2025, Net Income fell 26.46% year-over-year to -$24.9 million; the TTM value through Dec 2025 reached -$92.0 million, down 23.36%, while the annual FY2025 figure was -$91.8 million, 21.24% down from the prior year.
  • Net Income reached -$24.9 million in Q4 2025 per NGNE's latest filing, down from -$21.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$11.9 million in Q2 2023 to a low of -$24.9 million in Q4 2025.
  • Average Net Income over 3 years is -$18.3 million, with a median of -$18.9 million recorded in 2024.
  • Peak YoY movement for Net Income: plummeted 52.69% in 2024, then decreased 3.74% in 2025.
  • A 3-year view of Net Income shows it stood at -$14.0 million in 2023, then tumbled by 40.87% to -$19.7 million in 2024, then fell by 26.46% to -$24.9 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Net Income are -$24.9 million (Q4 2025), -$21.1 million (Q3 2025), and -$23.2 million (Q2 2025).